Read More Pharma Industry News What clinicians and regulators will watch next after Itvisma’s positive CHMP opinion Novartis Pharma AG’s Itvisma gains CHMP backing. Discover what clinicians, regulators, and investors will watch next in SMA gene therapy. bySoujanya RaviApril 26, 2026